For its fourth fiscal quarter (ending September 30), Cabot Corp (NYSE: CBT) has reported a 148% increase in E.P.S. from $1.65 a year ago to $4.10 in the current quarter. This performance was $2.62 better […]
ICU Medical Inc (NASDAQ: ICUI) has reported earnings for its third fiscal quarter (ending September 30) of $0.30 versus a loss $-0.55 for the same period a year ago. This result fell short of the […]
Allied Motion Technologies Inc (NASDAQ: AMOT) stock closed at $25.49 on 11/2/23 after a major decline of -10.2%. The stock has been weak relative to the market over the last nine months and has declined […]
Bank of Hawaii Corp (NYSE: BOH). Notable positive changes in fundamentals have recently occurred: significant quarterly sales acceleration occurred, the consensus estimate for December, 2023 increased significantly, and significant quarterly earnings acceleration occurred. Significant positive […]
CRA International Inc (NASDAQ: CRAI) stock closed at $83.47 on 11/2/23 after a major decline of -14.1%. The stock has performed in line with the market over the last nine months and has declined -13.8% […]
BALL CORP (NYSE: BALL) has reported E.P.S. of $0.64 for its third fiscal quarter (ending September 30) versus $1.25 for the same period a year ago — a decline of -49%. Relative to the consensus […]
For its third fiscal quarter (ending September 30), DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported E.P.S. of $-1.25 compared to $-5.01 a year ago. This performance was $-1.74 short of the consensus estimate of $0.49. […]
Sealed Air Corp (NYSE: SEE) has reported E.P.S. of $0.40 for its third fiscal quarter (ending September 30) versus $0.91 for the same period a year ago — a decline of -56%. This performance was […]
For its third fiscal quarter (ending September 30), Baxter International Inc (NYSE: BAX) has reported E.P.S. of $0.09 compared to $-5.94 a year ago. This result fell short of the consensus estimate of $0.69 by […]
On 11/2/23, Pediatrix Medical Group Inc (NYSE: MD) stock suffered a major decline of -11.8%, closing at $9.89. Relative to the market the stock has been weak over the last nine months and has declined […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research